Ungar R, Wu L, MacLeod S, Tkatch R, Huang J, Kraemer S, Schaffer J, Yeh C. The impact of COVID-19 on older adults: results from an annual survey. Geriatr Nurs. 2022 Mar;44:131-6. doi: 10.1016/j.gerinurse.2022.01.010
MacLeod S, Musich S, Kraemer S, Wicker E. Practical non-pharmacological intervention approaches for sleep problems among older adults. Geriatr Nurs. 2018 Sep;39(5):506-12. doi: 10.1016/j.gerinurse.2018.02.002
Tkatch R, Musich S, MacLeod S, Kraemer S, Hawkins K, Wicker ER, Armstrong DG. A qualitative study to examine older adults' perceptions of health: Keys to aging successfully. Geriatr Nurs. 2017 Nov;38(6):485-90. doi: 10.1016/j.gerinurse.2017.02.009
MacLeod S, Musich S, Gulyas S, Cheng Y, Tkatch R, Cempellin D, Bhattarai GR, Hawkins K, Yeh CS. The impact of inadequate health literacy on patient satisfaction, healthcare utilization, and expenditures among older adults. Geriatr Nurs. 2017 Jul;38(4):334-41. doi: 10.1016/j.gerinurse.2016.12.003
MacLeod S, Musich S, Hawkins K, Alsgaard K, Wicker ER. The impact of resilience among older adults. Geriatr Nurs. 2016 Jul;37(4):266-72. doi: 10.1016/j.gerinurse.2016.02.014
Shakoor A, Esterberg E, Acharya NR. Recurrence of uveitis after discontinuation of infliximab. Ocul Immunol Inflamm. 2014 Apr;22(2):96-101. doi: 10.3109/09273948.2013.812222
Brown TM, Horblyuk RV, Grotzinger KM, Matzdorff AC, Pashos CL. Patient-reported treatment burden of chronic immune thrombocytopenia therapies. BMC Blood Disord. 2012 Mar 1;12(1):2.
Martel JN, Esterberg E, Nagpal A, Acharya NR. Infliximab and adalimumab for uveitis. Ocul Immunol Inflamm. 2012 Feb;20(1):18-26. doi: 10.3109/09273948.2011.633205.
Earnshaw SR, Wilson M, Joshi AV. The effect of recombinant activated factor VII in the treatment of intracerebral hemorrhage on health plan budgets. Managed Care Interface. 2007 Jan 1;19(11):39-45.
Earnshaw SR, Wilson MR, Joshi AV. Health plan budget impact analysis of recombinant activated factor VII (rFVIIa) in the treatment of intracerebral hemorrhage. Managed Care Interface. 2006;19(11):39-45.
Earnshaw SR, Candrilli SD, Fernandes AW, Higashi MK. A cost-effectiveness analysis of antibiotic therapy in macrolide-resistant community-acquired pneumonia. Managed Care Interface. 2005 Oct 1;18(10):36-44.